We used the sodium-glucose cotransporter 2 inhibitor, luseogliflozin in two patients with diabetes mellitus with Child–Pugh classification B cirrhosis and cirrhotic ascites. The gene discussed is SLC5A2; the disease is diabetes mellitus.